TP53 and extranodal nasal NK/T cell lymphoma: Interestingly, TP53 was comparatively less mutated in NKTCL than other solid tumors, and those patients with TP53 mutations are usually with advanced stages, which collectively suggests the TP53 mutation as a secondary driver in NKTCL [11].